Circular RNAs in vascular diseases

Q Liu, Y Wang, T Zhang, J Fang… - Frontiers in Cardiovascular …, 2023 - frontiersin.org
Vascular diseases are the leading cause of morbidity and mortality worldwide and are
urgently in need of diagnostic biomarkers and therapeutic strategies. Circular RNAs …

Glucagon-like peptide-1 receptor agonists: new strategies and therapeutic targets to treat atherosclerotic cardiovascular disease

T Wang, J Ding, X Cheng, Q Yang, P Hu - Frontiers in Pharmacology, 2024 - frontiersin.org
Atherosclerotic cardiovascular disease (ASCVD) is a leading cause of cardiovascular
mortality and is increasingly prevalent in our population. Glucagon-like peptide-1 receptor …

CircLZIC regulates ox-LDL-induced HUVEC cell proliferation and apoptosis via Micro-330-5p/NOTCH2 axis in atherosclerosis

X Men, A Hu, T Xu - Clinical Hemorheology and …, 2024 - content.iospress.com
Atherosclerosis (AS) is a major chronic non-communicable disease and a primary cause of
cardiovascular disease. Recent studies have shown that circRNAs are potential epigenetic …

Identification and characterization of extrachromosomal circular DNA in large‐artery atherosclerotic stroke

K Chen, Y Chi, H Cheng, M Yang, Q Tan… - Journal of Cellular …, 2024 - Wiley Online Library
Extrachromosomal circular DNA (eccDNA) is a new biomarker and regulator of diseases.
However, the role of eccDNAs in large‐artery atherosclerotic (LAA) stroke remains unclear …

Secreted frizzled-related protein 5 overexpression reverses oxLDL-induced lipid accumulation in human vascular smooth muscle cells

X Wang, S Chen, C Yu, R Lu, Y Sun… - Bioscience …, 2024 - academic.oup.com
Atherosclerosis (AS) is the major cause of multiple cardiovascular diseases. In addition, the
lipid accumulation of human vascular smooth muscle cells (HVSMCs) can cause the …